NASDAQ:EIGR - Eiger Biopharmaceuticals News Headlines

$10.67
-0.07 (-0.65 %)
(As of 07/23/2019 04:00 PM ET)
Today's Range
$10.48
Now: $10.67
$10.87
50-Day Range
$9.48
MA: $10.67
$11.86
52-Week Range
$8.40
Now: $10.67
$15.33
Volume84,500 shs
Average Volume179,289 shs
Market Capitalization$205.50 million
P/E RatioN/A
Dividend YieldN/A
Beta1.07

Headlines

Eiger Biopharmaceuticals (NASDAQ EIGR) News Headlines

Source:
DateHeadline
Small Peninsula biotech targets big impact on deadly childhood aging diseaseSmall Peninsula biotech targets big impact on deadly childhood aging disease
finance.yahoo.com - July 18 at 7:13 PM
Need To Know: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Insiders Have Been Buying SharesNeed To Know: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Insiders Have Been Buying Shares
finance.yahoo.com - July 11 at 6:25 PM
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Receives Consensus Rating of "Buy" from AnalystsEiger Biopharmaceuticals Inc (NASDAQ:EIGR) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 9 at 6:35 AM
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Expected to Post Earnings of -$0.78 Per ShareEiger Biopharmaceuticals Inc (NASDAQ:EIGR) Expected to Post Earnings of -$0.78 Per Share
www.americanbankingnews.com - July 4 at 6:16 PM
Eiger BioPharmaceuticals: NDA For HGPS, Phase 3 Ongoing In HDV, Solid PotentialEiger BioPharmaceuticals: NDA For HGPS, Phase 3 Ongoing In HDV, Solid Potential
seekingalpha.com - June 26 at 6:41 PM
Hedge Funds Have Never Been This Bullish On Eiger BioPharmaceuticals, Inc. (EIGR)Hedge Funds Have Never Been This Bullish On Eiger BioPharmaceuticals, Inc. (EIGR)
finance.yahoo.com - June 20 at 7:51 PM
The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock SaleThe Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale
www.benzinga.com - June 18 at 7:46 AM
Eiger BioPharma +4.9% as avexitide designated Breakthrough TherapyEiger BioPharma +4.9% as avexitide designated Breakthrough Therapy
seekingalpha.com - June 17 at 8:03 PM
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH)Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH)
finance.yahoo.com - June 17 at 8:03 PM
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory AffairsEiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
finance.yahoo.com - June 10 at 8:33 AM
Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical DevelopmentEiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development
finance.yahoo.com - June 5 at 8:18 AM
Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare ConferenceEiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 30 at 8:28 AM
Eiger operating chief to bid adieuEiger operating chief to bid adieu
seekingalpha.com - May 18 at 7:39 AM
Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical OfficerEiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer
finance.yahoo.com - May 18 at 7:39 AM
Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business UpdateEiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
www.prnewswire.com - May 9 at 7:45 PM
Eiger to Present at ChinaBio® Partnering Forum 2019Eiger to Present at ChinaBio® Partnering Forum 2019
finance.yahoo.com - April 30 at 8:18 AM
Do Institutions Own Shares In Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)?Do Institutions Own Shares In Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)?
finance.yahoo.com - April 26 at 6:56 PM
Eiger BioPharmaceuticals Inc.Eiger BioPharmaceuticals Inc.
www.barrons.com - April 18 at 7:41 PM
Eiger Bio prices stock offering at $11Eiger Bio prices stock offering at $11
seekingalpha.com - April 18 at 8:20 AM
Eiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of DirectorsEiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of Directors
finance.yahoo.com - April 15 at 7:24 PM
Eigers lambda interferon shows positive effect in mid-stage HDV studyEiger's lambda interferon shows positive effect in mid-stage HDV study
seekingalpha.com - April 11 at 7:44 PM
Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress™ 2019Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress™ 2019
finance.yahoo.com - April 11 at 7:44 PM
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019
finance.yahoo.com - March 25 at 7:35 PM
Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019
finance.yahoo.com - March 20 at 8:16 AM
Eiger BioPharmaceuticals, Inc. Estimate MomentumEiger BioPharmaceuticals, Inc. Estimate Momentum
www.nasdaq.com - March 19 at 8:37 AM
What Makes Eiger BioPharma (EIGR) a New Buy StockWhat Makes Eiger BioPharma (EIGR) a New Buy Stock
finance.yahoo.com - March 15 at 7:28 PM
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdateEiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
www.prnewswire.com - March 15 at 8:30 AM
Eiger BioPharmaceuticals, Inc. EIGR Files An 8-K Entry into a Material Definitive AgreementEiger BioPharmaceuticals, Inc. EIGR Files An 8-K Entry into a Material Definitive Agreement
www.marketwatch.com - March 15 at 8:30 AM
Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019 - PRNewswireEiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019 - PRNewswire
www.prnewswire.com - March 14 at 7:20 PM
Eiger BioPharma: 4Q Earnings SnapshotEiger BioPharma: 4Q Earnings Snapshot
finance.yahoo.com - March 14 at 7:20 PM
Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019
finance.yahoo.com - March 13 at 8:14 AM
Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor SummitEiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit
finance.yahoo.com - March 11 at 7:42 PM
[$$] Five Best: Susan Froderberg on Extraordinary Mountain Ascents[$$] Five Best: Susan Froderberg on Extraordinary Mountain Ascents
finance.yahoo.com - March 8 at 7:50 PM
Clinigen and Eiger BioPharmaceuticals Launch Worldwide Managed Access Program for Lonafarnib for Patients with Progeria and Progeroid LaminopathiesClinigen and Eiger BioPharmaceuticals Launch Worldwide Managed Access Program for Lonafarnib for Patients with Progeria and Progeroid Laminopathies
finance.yahoo.com - March 4 at 7:37 AM
Eiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance OfficerEiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance Officer
finance.yahoo.com - February 27 at 8:20 AM
Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and JapanEiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan
finance.yahoo.com - February 6 at 8:24 AM
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New OrleansEiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans
finance.yahoo.com - February 5 at 7:17 AM
Baird sees 244% upside in Eiger Bio in premarket analyst actionBaird sees 244% upside in Eiger Bio in premarket analyst action
seekingalpha.com - January 29 at 6:13 PM
Eiger Receives Bevy Of Regulatory Support To Guide, Protect, And Accelerate HDV And Progeria ProgramsEiger Receives Bevy Of Regulatory Support To Guide, Protect, And Accelerate HDV And Progeria Programs
seekingalpha.com - January 28 at 8:17 AM
Eiger BioPharmaceuticals Appoints Regulatory Expert and Industry Veteran Christine Murray, MS, RAC to its Board of DirectorsEiger BioPharmaceuticals Appoints Regulatory Expert and Industry Veteran Christine Murray, MS, RAC to its Board of Directors
finance.yahoo.com - January 7 at 8:15 AM
Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International,Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International,
www.nasdaq.com - December 31 at 8:19 AM
Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International, Eiger BioPharmaceuticals, China Automotive, and Moleculin Biotech — New Horizons, Emerging Trends, and Upcoming DevelopmentsReport: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International, Eiger BioPharmaceuticals, China Automotive, and Moleculin Biotech — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - December 31 at 8:19 AM
Have Insiders Been Buying Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Shares?Have Insiders Been Buying Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Shares?
finance.yahoo.com - December 21 at 5:30 PM
FDA grants accelerated review status for Eiger Bios lonafarnib for rare accelerated aging disorderFDA grants accelerated review status for Eiger Bio's lonafarnib for rare accelerated aging disorder
seekingalpha.com - December 19 at 5:50 PM
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid LaminopathiesEiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies
finance.yahoo.com - December 19 at 8:20 AM
Eiger BioPharmaceuticals (EIGR) Reports Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus Infection - StreetInsider.comEiger BioPharmaceuticals (EIGR) Reports Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus Infection - StreetInsider.com
www.streetinsider.com - December 18 at 5:35 PM
Eiger BioPharmaceuticals (EIGR) Announces PRIME Designation Granted by EMA for Lonafarnib for Treatment of Hepatitis Delta Virus Infection - StreetInsider.comEiger BioPharmaceuticals (EIGR) Announces PRIME Designation Granted by EMA for Lonafarnib for Treatment of Hepatitis Delta Virus Infection - StreetInsider.com
www.streetinsider.com - December 18 at 5:35 PM
Eiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus InfectionEiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus Infection
finance.yahoo.com - December 18 at 8:21 AM
Eiger Bios lonafarnib nabs accelerated review status in U.S. for HDV infectionEiger Bio's lonafarnib nabs accelerated review status in U.S. for HDV infection
seekingalpha.com - December 17 at 5:43 PM
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) InfectionEiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection
finance.yahoo.com - December 17 at 8:17 AM
This page was last updated on 7/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel